ARC Desk

Artificial Intelligence for Drug Discovery Market to Reach US$ 8,149 Mn by 2026

Uutinen   •   Tammi 06, 2020 08:34 EET

The global Artificial Intelligence for Drug Discovery Market Size is set to reach over US$ 8,149 million by 2026 and will grow at CAGR 42% during the forecast period 2019-2026. Acumen Research and Consulting, Latest Research Report on titled “Artificial Intelligence for Drug Discovery Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”.

In the coming years, the global Artificial Intelligence for Drug Discovery Market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2026. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global Artificial Intelligence for Drug Discovery Market, the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1621

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry. The market share of the global Artificial Intelligence for Drug Discovery Market is dominated by companies like Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics, Cloud Pharmaceuticals, Inc., BenevolentAI, twoXAR, and Exscientia. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global Artificial Intelligence for Drug Discovery Market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the Artificial Intelligence for Drug Discovery Market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the Artificial Intelligence for Drug Discovery Market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the Artificial Intelligence for Drug Discovery Market in terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

Market by Drug Type:

  • Small Molecule
  • Large Molecule

Market by Technology:

  • Deep Learning
  • Machine Learning

Market by Application:

  • Metabolic Disease
  • Cardiovascular Diseases
  • Oncology
  • Neurodegenerative Diseases
  • Others

Market by End use:

  • Pharmaceutical & Biotechnological Companies
  • Academic & Research Institutes
  • Others

Market by Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest if Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Meddle East & Africa

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global Artificial Intelligence for Drug Discovery Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Artificial Intelligence for Drug Discovery
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Artificial Intelligence for Drug Discovery Market By Drug Type
1.2.2.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Drug Type (2015-2026)
1.2.2.2. Global Artificial Intelligence for Drug Discovery Market Revenue Share By Drug Type in 2018
1.2.2.3. Small Molecule
1.2.2.4. Large Molecule
1.2.3. Artificial Intelligence for Drug Discovery Market By Technology
1.2.3.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Deep Learning
1.2.3.3. Machine Learning
1.2.4. Artificial Intelligence for Drug Discovery Market By Application
1.2.4.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Metabolic Disease
1.2.4.3. Cardiovascular Diseases
1.2.4.4. Oncology
1.2.4.5. Neurodegenerative Diseases
1.2.4.6. Others
1.2.5. Artificial Intelligence for Drug Discovery Market By End use
1.2.5.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.5.2. Pharmaceutical & Biotechnological Companies
1.2.5.3. Academic & Research Institutes
1.2.5.4. Others
1.2.6. Artificial Intelligence for Drug Discovery Market By Geography
1.2.6.1. Global Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.3. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.4. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.5. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)
1.2.6.6. Middle East and Africa (MEA)Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Artificial Intelligence for Drug Discovery Major Manufacturers in 2018

CHAPTER 4. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY DRUG TYPE
4.1. Global Artificial Intelligence for Drug Discovery Revenue By Drug Type
4.2. Small Molecule
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Large Molecule
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY TECHNOLOGY
5.1. Global Artificial Intelligence for Drug Discovery Revenue By Technology
5.2. Deep Learning
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Machine Learning
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY APPLICATION
6.1. Global Artificial Intelligence for Drug Discovery Revenue By Application
6.2. Metabolic Disease
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cardiovascular Diseases
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Oncology
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Neurodegenerative Diseases
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET By END USE
7.1. Global Artificial Intelligence for Drug Discovery Revenue By End Use
7.2. Pharmaceutical & Biotechnological Companies
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Academic & Research Institutes
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Others
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
8.1. North America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Artificial Intelligence for Drug Discovery Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
9.1. Europe Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
10.1. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.6.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.7.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.8.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
11.1. Latin America Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE FOR DRUG DISCOVERY MARKET BY COUNTRY
12.1. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa Artificial Intelligence for Drug Discovery Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Drug Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.4. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Atomwise, Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Insilico Medicine
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. BIOAGE
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Numerate
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. NuMedii, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Envisagenics
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Cloud Pharmaceuticals, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. BenevolentAI
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. twoXAR
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Exscientia
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1621

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com